← Open Payments lookup

BINA SALEH: Open Payments

NPI 1336517127 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,393 in 78 payments from 15 companies in 2025. Trend: 2023 $1,649 · 2024 $1,315 · 2025 $1,393

Food & beverage: $1,393
CompanyPaymentsAmount
ABBVIE INC.23$320
Alkermes, Inc.9$216
Neurocrine BioSciences, Inc.11$165
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$150
Tris Pharma Inc7$138
Lundbeck LLC6$129
Takeda Pharmaceuticals U.S.A., Inc.5$90
E.R. Squibb & Sons, L.L.C.2$43
Janssen Pharmaceuticals, Inc1$28
Teva Pharmaceuticals USA, Inc.2$28

Products named: VRAYLAR, ARISTADA, INGREZZA, CAPLYTA, Dyanavel XR, TRINTELLIX, REXULTI, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.